Literature DB >> 26991258

Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.

Mohamed Rowisha1, Manal El-Batch2, Thanaa El Shikh2, Salwa El Melegy2, Hany Aly3.   

Abstract

BACKGROUND: Obesity in adolescents has quadrupled in the past 30 y. Markers for cardiovascular risks are needed in this population. We hypothesized that soluble receptor for advanced glycation end products (sRAGE) and asymmetric dimethyl arginine (ADMA) can correlate with carotid intima-media thickness (cIMT), a known index of subclinical atherosclerosis. We also aimed to evaluate the frequency of (Gly82Ser) RAGE gene polymorphism in obese adolescents.
METHODS: Obese and nonobese adolescents were evaluated in a cross-sectional study for lipid profile, insulin resistance, ADMA, sRAGE, and RAGE gene (Gly 82 Ser) polymorphism. We measured cIMT in all subjects and performed correlation analyses with all markers.
RESULTS: The study included 50 obese and 40 healthy control adolescents. Compared to controls, obese subjects had less sRAGE (P = 0.02) and greater cIMT (P = 0.006), insulin resistance (P < 0.0001), and ADMA (P < 0.0001). In a multivariate linear regression model, sRAGE was associated with cIMT (β = 0.28, P = 0.04). Both GS and SS genotypes of RAGE were more frequent in obese than controls (P = 0.04).
CONCLUSION: Increased ADMA and decreased sRAGE are associated with cardiovascular risks in obese adolescents. The S allele in RAGE gene is more frequently detected with obesity. The role of RAGE gene and mechanisms leading to cardiovascular risks need further studying.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26991258     DOI: 10.1038/pr.2016.55

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  32 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts.

Authors:  Mari Osawa; Yasuhiko Yamamoto; Seiichi Munesue; Naho Murakami; Shigeru Sakurai; Takuo Watanabe; Hideto Yonekura; Yasuko Uchigata; Yasuhiko Iwamoto; Hiroshi Yamamoto
Journal:  Biochim Biophys Acta       Date:  2007-07-19

Review 3.  Advanced glycation end products and insulin resistance.

Authors:  Hiroyuki Unoki; Sho-ichi Yamagishi
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

4.  Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients.

Authors:  Ashok Kumar Tripathi; Diwesh Chawla; Savita Bansal; Basu Dev Banerjee; Sri Venkata Madhu; Om Prakash Kalra
Journal:  Diabetes Res Clin Pract       Date:  2013-12-25       Impact factor: 5.602

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 6.  Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  J Recept Signal Transduct Res       Date:  2011-10       Impact factor: 2.092

Review 7.  Cellular signalling of the receptor for advanced glycation end products (RAGE).

Authors:  Jianling Xie; José D Méndez; Verna Méndez-Valenzuela; María Montserrat Aguilar-Hernández
Journal:  Cell Signal       Date:  2013-07-06       Impact factor: 4.315

8.  Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease.

Authors:  Ajay Duseja; Kiran K Thumburu; Ashim Das; R K Dhiman; Y K Chawla; S Bhadada; Anil Bhansali
Journal:  Indian J Gastroenterol       Date:  2007 Jul-Aug

9.  The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease.

Authors:  Latika Sibal; Sharad C Agarwal; Philip D Home; Rainer H Boger
Journal:  Curr Cardiol Rev       Date:  2010-05

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  4 in total

1.  Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.

Authors:  Radana Gurecká; Ivana Koborová; Melinda Csongová; Jozef Šebek; Katarína Šebeková
Journal:  Glycoconj J       Date:  2016-06-14       Impact factor: 2.916

Review 2.  Does AGE-RAGE Stress Play a Role in the Development of Coronary Artery Disease in Obesity?

Authors:  Kailash Prasad; Amal S Khan; Kalpana K Bhanumathy
Journal:  Int J Angiol       Date:  2022-02-12

Review 3.  Glycation & the RAGE axis: targeting signal transduction through DIAPH1.

Authors:  Alexander Shekhtman; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Expert Rev Proteomics       Date:  2016-12-22       Impact factor: 3.940

4.  Polymorphisms of the receptor for advanced glycation end products as vasculopathy predictor in sickle cell disease.

Authors:  Nesma Ahmed Safwat; Mai Mohamed ELkhamisy; Soha Ezz AlArab Abdel-Wahab; Mohamed Tarif Hamza; Noha Hussein Boshnak; Mahmoud Adel Kenny
Journal:  Pediatr Res       Date:  2020-06-16       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.